The management of neuropathic pain in cancer

Progress in Palliative Care

Volumn 16, Issue 1, 2008, Pages 7-13

  Searle, Robert D ^a   Bennett, Michael ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Cancer; Management; Neuropathic pain; Review

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUPRENORPHINE; CARBAMAZEPINE; DIAZEPAM; DULOXETINE; FENTANYL; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MAGNESIUM; MEXILETINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; OMEGA CONOTOXIN MVIIA; OXYCODONE; PHENYTOIN; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACUPUNCTURE; ALLODYNIA; AUTONOMIC DYSFUNCTION; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; COGNITIVE DEFECT; CORDOTOMY; DIABETIC NEUROPATHY; DRUG CHOICE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; HUMAN; KIDNEY DYSFUNCTION; LIVER DYSFUNCTION; MONOTHERAPY; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; REVIEW; SPINAL CORD STIMULATION; SYMPATHETIC BLOCKING; SYSTEMIC DISEASE; TRANSCUTANEOUS NERVE STIMULATION; TRIGEMINUS NEURALGIA; UNSPECIFIED SIDE EFFECT;

EID: 49749099668     PISSN: 09699260     EISSN: None     Source Type: Journal    
DOI: 10.1179/096992608X291207     Document Type: Review

References (55)

1. Merskey H, Bogduk N. Classification of chronic pain. Seattle, WA: IASP, 1994.
2. Denmark A. An example of symptoms resembling tic douloureux produced by a wound in the radial nerve. Med Chir Trans London 1813; 3: 48-52.
3. Behan RJ. Pain: Its origin, conduction, perception and diagnostic significance. New York: V Appleton, 1914; 198-203.
4. Riddoch G. The clinical features of central pain. Lancet 1938; 234: 1093-1098. 1150-1156, 1205-1209.
5. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. Pain 1999; 82: 263-274
6. Bennett M. The LANSS Pain Scale: The Leeds assessment of neuropathic symptoms and signs. Pain 2001; 92: 147-157.
7. Potter J, Higginson, IJ, Scadding. JW. Quigley CW. Identifying neuropathic pain in patients with head and neck cancer: Use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale. J R Soc Med 2003; 96: 379-383.
8. Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Long lasting analgesic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005; 76: 833-838.
9. Rowbotham MC, Reisner-Keller LA, Fields HL. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology, 1991; 41: 1024-1028.
10. Jadad AR, Carroll D, Glynn CJ et al. Morphine responsiveness of chronic pain. double-blind randomized crossover study with patient-controlled analgesia. Lancet 1992; 339: 1367-1371.
11. Raja SN, Haythornthwaite JA, Pappagallo M et al. Opioids versus antidepressants in postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2002; 59: 1015-1021
12. Gilron I, Bailey JM, Dongsheng TU et al. Morphine, gabapentin, or their combination for neuropathic pain. N Eng J Med 2005; 352: 1324-1334.
13. Finnerup NB, Otto M, McQauy HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 2005; 118: 289-305.
14. Dellemijn P, Vanneste JA. Randomized double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet 1997; 349: 753-758.
15. Dellemijn PL, van Duijn H, Vanneste JA. Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 1998; 16: 220-229.
16. Watson CPN, Babul N. Efficacy of oxycodone in neuropathic pain a randomized trial in post herpetic neuralgia. Neurology 1998: 50: 1837-1841.
17. Watson CPN, Moulin D, Watt-Watson J el al. Controlled-release oxycodone relieves neuropathic pain; a randomized controlled trial in painful diabetic neuropathy Pain 2003; 105: 71-78.
18. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial. Neurology 2003: 60: 927-934.
19. Dulimke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2004, (2): CD 003726.
20. Benedetti F. Vighetti S, Amanzio M et al. Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain. Pain 1998; 74: 205-211.
21. Berger A, Mercadante S, Oster G. Use of antiepileptics and tricyclic antidepressants in cancer patients with neuropathic pain. Eur J Cancer Care 2005; 15: 138-145.
22. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005; (3): CD005454.
23. Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: A randomized placebo-controlled, double-blind crossover study. Tumori 2002; 88: 239-242.
24. Reuben SS, Makari-Judson G, Lurie SD. Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manage 2004; 27: 133-139.
25. Rice AS, Maton S, Post-therapeutic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001; 94: 215-224.
26. Backonja A, Beydoun A, Edwards KR et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. JAMA 1998; 280: 1831-1836.
27. Serpell M, Neuropathic Pain Study Group. Gabapentin in neuropathic pain syndromes: A randomised, double blind, placebo controlled trial. Pain 2002; 99: 557-566.
28. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev 2005; 3: CD001133.
29. Caraceni A, Zecca E Bonezzi C et al. Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group. J Clin Oncol 2004; 14: 2909-2917.
30. Bennett MI. Gabapentin significantly improves analgesia in people receiving opioids for neuropathic cancer pain. Cancer Treatment Rev 2005; 31: 58-62.
31. Ross JR, Goller K, Hardy J et al. Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. J Palliat Med 2005; 8: 1118-1126.
32. Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a co-analgesic in cancer pain. J Pain Symptom Manage 1992; 7: 209-213.
33. Chang VT. Intravenous phenytoin in the management of crescendo pelvic cancer-related pain. J Pain Symptom Manage 1997; 13: 238-240.
34. Hardy JR, Rees EA, Gwilliam B, Ling J, Broadley K, A'Hern R. A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage 2001; 21: 204-209.
35. Devulder JE. Lamotrigine in refractory cancer pain. A case report. J Clin Anesth 2000; 12: 574-575.
36. Dunteman ED. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: Case series and commentary. J Pain Palliat Care Pharmacother 2005; 19: 35-43.
37. Jackson K, Ashby M, Martin P et al. 'Burst' ketamine for refractory cancer pain: An open-label audit of 39 patients. J Pain Symptom Manage 2001; 22: 834-842.
38. Mercadante S, Arcuri JE, Tirelli W, Casuccio A. Analgesic effects of intravenous ketamine in cancer patients on morphine therapy: A randomised double blind, crossover, double-dose study. J Pain Symptom Manage 2000; 20: 246-252.
39. Crosby V, Wilcock A, Corcoran R. The safety and efficacy of a single dose (500 mg or 1 g) of intravenous magnesium sulphate in neuropathic pain poorly responsive to strong opioid analgesics in patients with cancer. J Pain Symptom Manage 2000; 19: 35-39.
40. Ellemann K, Sjogren P, Banning AM, Jensen TS. Smith T, Geertson P. Trial of intravenous lidocaine on painful neuropathy in cancer patients. Clin J Pain 1989: 5: 291-294.
41. Bruera E, Ripamonti C, Brenncis C, Macmillan K, Hanson J. A randomized double-blind crossover trial of intravenous lidocaine in the treatment of neuropathic cancer pain. J Pain Symptom Manage 1992; 7: 138-140.
42. Challapalli V. Tremont-Lukats IW, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 2005: (4): CD003345.
43. Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancer related pain: A systematic review. Eur J Pain 2005; 9: 437-444
44. Krames E. Implantable devices for pain control: Spinal cord stimulation and intrathecal therapies. Best Prac Res Clin Anaesthesiol 2002; 16: 619-649.
45. Prager J, Jacobs M. Evaluation of patients for implantable pain modalities: Medical and behavioural assessment. Clin J Pain 2001. 17: 206-214.
46. Krames ES. Practical issues when using neuraxial infusion. Oncology 1999; 13 (Suppl 2): 37-44.
47. Hassenbusch SJ, Portenoy RK, Cousins M et al. Polyanalgesic Consensus Conference 2003: An update on the management of pain by intraspinal drug delivery - report of an expert panel. J Pain Symptom Manage 2004; 27: 540-563.
48. Staats PS, Yearwood T, Charapata SG et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. JAMA 2004: 291: 63-70.
49. Mailis A, Furlan A: Sympathectomy for neuropathic pain. Cochrane Database Syst Rev 2003; Issue 2.
50. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: A meta-analysis. Anesth Analg 1995; 80: 290-295.
51. Wong GY, Schroeder DR, Carns PE et al. Effect of neurolytic celiac plexus block on pain relief, quality of life and survival in patients with unresectable pancreatic cancer. JAMA 2004; 291; 1092-1099.
52. Cata J, Cordiella J, Burton AW, Dougherty Y, Hassenbusch SJ. Spinal cord stimulation effectively treats chemotherapy induced peripheral neuropathy. J Pain Symptom Manage 2004; 27: 72-78.
53. Crul BJ, Blok LM, van Egmond J, van Dongen RT. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain 2005; 6: 24-29.
54. Grond S, Radbruch L, Meuser T et al. Assessment and treatment of neuropathic cancer patients following WHO guidelines. Pain 1999; 79: 15-20.
55. Attal N, Cruccu G, Haanpaa M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.